These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 8177735)

  • 1. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2.
    Nan X; Meehan RR; Bird A
    Nucleic Acids Res; 1993 Oct; 21(21):4886-92. PubMed ID: 8177735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation specifies chromosomal localization of MeCP2.
    Nan X; Tate P; Li E; Bird A
    Mol Cell Biol; 1996 Jan; 16(1):414-21. PubMed ID: 8524323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chicken MAR-binding protein ARBP is homologous to rat methyl-CpG-binding protein MeCP2.
    Weitzel JM; Buhrmester H; Strätling WH
    Mol Cell Biol; 1997 Sep; 17(9):5656-66. PubMed ID: 9271441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
    Nan X; Ng HH; Johnson CA; Laherty CD; Turner BM; Eisenman RN; Bird A
    Nature; 1998 May; 393(6683):386-9. PubMed ID: 9620804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA.
    Chandler SP; Guschin D; Landsberger N; Wolffe AP
    Biochemistry; 1999 Jun; 38(22):7008-18. PubMed ID: 10353812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The solution structure of the domain from MeCP2 that binds to methylated DNA.
    Wakefield RI; Smith BO; Nan X; Free A; Soteriou A; Uhrin D; Bird AP; Barlow PN
    J Mol Biol; 1999 Sep; 291(5):1055-65. PubMed ID: 10518942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2).
    Valinluck V; Tsai HH; Rogstad DK; Burdzy A; Bird A; Sowers LC
    Nucleic Acids Res; 2004; 32(14):4100-8. PubMed ID: 15302911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins.
    Cross SH; Meehan RR; Nan X; Bird A
    Nat Genet; 1997 Jul; 16(3):256-9. PubMed ID: 9207790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
    Buschdorf JP; Strätling WH
    J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA.
    Ballestar E; Yusufzai TM; Wolffe AP
    Biochemistry; 2000 Jun; 39(24):7100-6. PubMed ID: 10852707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the matrix attachment region-binding domain of chicken MeCP2.
    Heitmann B; Maurer T; Weitzel JM; Strätling WH; Kalbitzer HR; Brunner E
    Eur J Biochem; 2003 Aug; 270(15):3263-70. PubMed ID: 12869202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA.
    Ohki I; Shimotake N; Fujita N; Jee J; Ikegami T; Nakao M; Shirakawa M
    Cell; 2001 May; 105(4):487-97. PubMed ID: 11371345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Schanen C; Tamura M
    J Med Genet; 2003 Jul; 40(7):487-93. PubMed ID: 12843318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome.
    Nan X; Bird A
    Brain Dev; 2001 Dec; 23 Suppl 1():S32-7. PubMed ID: 11738839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.
    Klose RJ; Sarraf SA; Schmiedeberg L; McDermott SM; Stancheva I; Bird AP
    Mol Cell; 2005 Sep; 19(5):667-78. PubMed ID: 16137622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells.
    Koch C; Strätling WH
    Biochemistry; 2004 May; 43(17):5011-21. PubMed ID: 15109260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
    Nan X; Campoy FJ; Bird A
    Cell; 1997 Feb; 88(4):471-81. PubMed ID: 9038338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tight interaction between densely methylated DNA fragments and the methyl-CpG binding domain of the rat MeCP2 protein attached to a solid support.
    Shiraishi M; Sekiguchi A; Chuu YH; Sekiya T
    Biol Chem; 1999 Sep; 380(9):1127-31. PubMed ID: 10543452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA.
    Liu K; Xu C; Lei M; Yang A; Loppnau P; Hughes TR; Min J
    J Biol Chem; 2018 May; 293(19):7344-7354. PubMed ID: 29567833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.